Charting the path of the deadly Ebola virus in central AfricaOctober 25, 2005Over the past ten years, separate outbreaks of the deadly Zaire strain of Ebola virus (ZEBOV) have killed hundreds of humans and tens of thousands of great apes in Gabon and the Republic of Congo-which harbor roughly 80% of the last remaining wild gorilla and chimpanzee populations. In a new study, Peter Walsh, Roman Biek, and Leslie Real combined genetic data with information on the timing and location of past ZEBOV outbreaks to support the hypothesis that a "consistently moving wave of ZEBOV infection" recently spread to outbreak sites in Gabon and Congo. In the prevailing view, ZEBOV arose from long-persistent local strains after increased contact between humans or great apes and an unidentified reservoir host. But Walsh et al. found support for the alternative hypothesis: that ZEBOV had recently spread to the outbreak regions. This is good news because a virus that spreads at a predictable rate in a predictable direction is far easier to control than one that emerges by chance or at the hands of an unknown trigger. The authors modeled the virus's spread based on assumptions of a long-persistent virus versus a recently emerged virus, and tested the predictions of these competing hypotheses using genetic data-gathered from gene sequences taken from human samples at the different outbreak sites-and information on the spatiotemporal dynamics of the outbreaks. Though the strength of the individual lines of evidence is not conclusive when considered separately, taken together, they support the view that ZEBOV is spreading as a wave from the first epidemic in Yambuku, Gabon. Following its current course, ZEBOV may hit populated areas east of Odzala National Park within 1-2 years and reach most parks containing large populations of western gorillas in 3-6 years. Two Ebola outbreaks have already hit human populations west of Odzala, and over the past two years, the largest gorilla and chimp populations in the world, found in Odzala, have been devastated-the disease is spreading to the last unaffected sector of the park right now. These findings suggest that strategies to protect villagers and some of the last remaining wild apes from future outbreaks would do best to concentrate efforts at the front of the advancing wave-and start acting now. Public Library of Science |
|||||||||||||||||||||
| Related Ebola Current Events and Ebola News Articles 1930s drug slows tumor growth Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. Exon-skipping drug prevents muscle wasting, maintains muscle function in dystrophin deficient mice An exon skipping PPMO has demonstrated dramatic effects in the prevention and treatment of severely affected, dystrophin and utrophin-deficient mice, preventing severe deterioration of the treated animals and extending their lifespan. Outfoxing pox: Developing a new class of vaccine candidates In the annals of medicine, Edward Jenner's 1796 vaccination of a young boy against smallpox, using fluid from cowpox blisters, remains a landmark case. In a new study, Kathryn Sykes, a researcher at Arizona State University's Biodesign Institute and her colleagues have taken a fresh look at cowpox. World will miss 2010 target to stem biodiversity loss, experts say The world will miss its agreed target to stem biodiversity loss by next year, according to experts convening in Cape Town for a landmark conference devoted to biodiversity science. Scientists block Ebola infection in cell-culture experiments Researchers at the University of Texas Medical Branch at Galveston have discovered two biochemical pathways that the Ebola virus relies on to infect cells. OHSU scientists partner with others to form center aimed at combating infectious diseases Oregon Health & Science University and the University of Washington, along with a number of partner institutions across the Northwest, have received federal funding to form a regional research center aimed at combating emerging or re-emerging infectious diseases that pose a serious threat to human health. Drug blocks 2 of world's deadliest emerging viruses Two highly lethal viruses that have emerged in recent outbreaks are susceptible to chloroquine, an established drug used to prevent and treat malaria, according to a new basic science study by researchers at Weill Cornell Medical College in the Journal of Virology. Penn Study Identifies How Ebola Virus Avoids the Immune System Researchers at the University of Pennsylvania School of Medicine have likely found one reason why the Ebola virus is such a powerful, deadly, and effective virus. Using a cell culture model for Ebola virus infection, they have discovered that the virus disables a cellular protein called tetherin that normally can block the spread of virus from cell to cell. Iowa State University researchers discover structure of key Ebola protein Research led by Iowa State University scientists has them a step closer to finding a way to counter the Ebola virus. UT Southwestern researchers develop new strategy for broad spectrum anti-viral drugs Bavituximab, an anti-viral drug developed by UT Southwestern Medical Center researchers, shows promise as a new strategy to fight viral diseases, including potential bioterrorism agents. More Ebola Current Events and Ebola News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||